These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Clinical Profile of Scleritis Presenting for the First Time in the Elderly. Magesan K; Surya J; Sridharan S; Nair V; Agarwal M; Agarwal AE; Biswas J; Dutta Majumder P Ocul Immunol Inflamm; 2023 May; 31(4):696-700. PubMed ID: 35522207 [TBL] [Abstract][Full Text] [Related]
27. Clinical characteristics of scleritis patients with emphasized comparison of associated systemic diseases (anti-neutrophil cytoplasmic antibody-associated vasculitis and rheumatoid arthritis). Yoshida A; Watanabe M; Okubo A; Kawashima H Jpn J Ophthalmol; 2019 Sep; 63(5):417-424. PubMed ID: 31183624 [TBL] [Abstract][Full Text] [Related]
28. Incidence of scleritis and episcleritis: results from the Pacific Ocular Inflammation Study. Homayounfar G; Nardone N; Borkar DS; Tham VM; Porco TC; Enanoria WT; Parker JV; Vinoya AC; Uchida A; Acharya NR Am J Ophthalmol; 2013 Oct; 156(4):752-8. PubMed ID: 23891336 [TBL] [Abstract][Full Text] [Related]
29. Management of noninfectious scleritis. Abdel-Aty A; Gupta A; Del Priore L; Kombo N Ther Adv Ophthalmol; 2022; 14():25158414211070879. PubMed ID: 35083421 [TBL] [Abstract][Full Text] [Related]
30. Autoimmunity in uveitis. Ten Berge JC; Schreurs MWJ; van Daele PLA; Rothova A Acta Ophthalmol; 2018 Aug; 96(5):481-485. PubMed ID: 29369534 [TBL] [Abstract][Full Text] [Related]
32. Clinical characteristics of a large cohort of patients with scleritis and episcleritis. Sainz de la Maza M; Molina N; Gonzalez-Gonzalez LA; Doctor PP; Tauber J; Foster CS Ophthalmology; 2012 Jan; 119(1):43-50. PubMed ID: 21963265 [TBL] [Abstract][Full Text] [Related]
33. Rituximab for non-infectious Uveitis and Scleritis. Ng CC; Sy A; Cunningham ET J Ophthalmic Inflamm Infect; 2021 Aug; 11(1):23. PubMed ID: 34396463 [TBL] [Abstract][Full Text] [Related]
34. Anterior scleritis: three case reports and a review of the literature. Castells DD Optometry; 2004 Jul; 75(7):430-44. PubMed ID: 15296376 [TBL] [Abstract][Full Text] [Related]
35. Incidence, prevalence, and risk factors of infectious uveitis and scleritis in the United States: A claims-based analysis. Zhang Y; Amin S; Lung KI; Seabury S; Rao N; Toy BC PLoS One; 2020; 15(8):e0237995. PubMed ID: 32841267 [TBL] [Abstract][Full Text] [Related]
36. Clinical Profile of Patients with Scleritis in Bangladesh. Rahman Z; Jafarullah O; Huq N; Hasan K; Magesan K; Dutta Majumder P Ocul Immunol Inflamm; 2021 Aug; 29(6):1102-1105. PubMed ID: 32130057 [No Abstract] [Full Text] [Related]
37. Uveitis and Scleritis as a Risk Factor for Mortality. Lim JZ; Samalia PD; Sims JL; Niederer RL Ocul Immunol Inflamm; 2024 Nov; 32(9):1929-1936. PubMed ID: 38833275 [TBL] [Abstract][Full Text] [Related]
38. Combined Ophthalmology and Rheumatology Evaluation in Systemic Autoimmune Diseases with Ocular Involvement: A Third Level Reference Center in Mexico. Baquero-Ospina P; Paquentín-Jiménez R; Hubbe-Tena C; Concha-Del-Rio LE Ocul Immunol Inflamm; 2023 Jul; 31(5):989-995. PubMed ID: 35759649 [TBL] [Abstract][Full Text] [Related]
39. [Scleritis and episcleritis: diagnosis and treatment]. Héron E; Gutzwiller-Fontaine M; Bourcier T Rev Med Interne; 2014 Sep; 35(9):577-85. PubMed ID: 24636988 [TBL] [Abstract][Full Text] [Related]
40. Evaluation of patients with scleritis for systemic disease. Akpek EK; Thorne JE; Qazi FA; Do DV; Jabs DA Ophthalmology; 2004 Mar; 111(3):501-6. PubMed ID: 15019326 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]